563 related articles for article (PubMed ID: 16099119)
1. Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles.
Ngaboni Okassa L; Marchais H; Douziech-Eyrolles L; Cohen-Jonathan S; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2005 Sep; 302(1-2):187-96. PubMed ID: 16099119
[TBL] [Abstract][Full Text] [Related]
2. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
Okassa LN; Marchais H; Douziech-Eyrolles L; Hervé K; Cohen-Jonathan S; Munnier E; Soucé M; Linassier C; Dubois P; Chourpa I
Eur J Pharm Biopharm; 2007 Aug; 67(1):31-8. PubMed ID: 17289360
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
Saxena V; Sadoqi M; Shao J
Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
[TBL] [Abstract][Full Text] [Related]
4. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
5. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.
Misra R; Acharya S; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818
[TBL] [Abstract][Full Text] [Related]
6. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.
Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Doolaanea AA
Drug Deliv Transl Res; 2016 Jun; 6(3):308-18. PubMed ID: 26817478
[TBL] [Abstract][Full Text] [Related]
8. The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye.
Raut SL; Kirthivasan B; Bommana MM; Squillante E; Sadoqi M
Nanotechnology; 2010 Oct; 21(39):395102. PubMed ID: 20820096
[TBL] [Abstract][Full Text] [Related]
9. Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi.
Mohammadi G; Valizadeh H; Barzegar-Jalali M; Lotfipour F; Adibkia K; Milani M; Azhdarzadeh M; Kiafar F; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Oct; 80(1):34-9. PubMed ID: 20558048
[TBL] [Abstract][Full Text] [Related]
10. Arsenic and chromium removal by mixed magnetite-maghemite nanoparticles and the effect of phosphate on removal.
Chowdhury SR; Yanful EK
J Environ Manage; 2010 Nov; 91(11):2238-47. PubMed ID: 20598797
[TBL] [Abstract][Full Text] [Related]
11. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
12. Dendrimer modified magnetite nanoparticles for protein immobilization.
Pan BF; Gao F; Gu HC
J Colloid Interface Sci; 2005 Apr; 284(1):1-6. PubMed ID: 15752777
[TBL] [Abstract][Full Text] [Related]
13. Optimization of maghemite-loaded PLGA nanospheres for biomedical applications.
Silva MF; Winkler Hechenleitner AA; de Oliveira DM; Agüeros M; Peñalva R; Irache JM; Pineda EA
Eur J Pharm Sci; 2013 Jun; 49(3):343-51. PubMed ID: 23602998
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of highly-magnetic biodegradable poly(d,l-lactide-co-glycolide) nanospheres.
Liu X; Kaminski MD; Chen H; Torno M; Taylor L; Rosengart AJ
J Control Release; 2007 May; 119(1):52-8. PubMed ID: 17350131
[TBL] [Abstract][Full Text] [Related]
15. Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting.
Arias JL; Gallardo V; Ruiz MA; Delgado AV
Eur J Pharm Biopharm; 2008 May; 69(1):54-63. PubMed ID: 18164927
[TBL] [Abstract][Full Text] [Related]
16. Brain targeting of Atorvastatin loaded amphiphilic PLGA-b-PEG nanoparticles.
Simşek S; Eroğlu H; Kurum B; Ulubayram K
J Microencapsul; 2013; 30(1):10-20. PubMed ID: 22734433
[TBL] [Abstract][Full Text] [Related]
17. Magnetic nanoparticles and rapamycin encapsulated into polymeric nanocarriers.
Oliveira RR; Ferreira FS; Cintra ER; Branquinho LC; Bakuzis AF; Lima EM
J Biomed Nanotechnol; 2012 Apr; 8(2):193-201. PubMed ID: 22515070
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents.
Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
[TBL] [Abstract][Full Text] [Related]
20. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles.
Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM
J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
